$MNTS
Momentus Inc. Stock $mnts

$mnts Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000178116222000023 Filed on March 09, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$0.00	$330.0K	$0.00
YoY Change		-9.59%
Cost Of Revenue		-$100.0K
YoY Change		-127.17%
Gross Profit		$465.0K
YoY Change		-15600.0%
Gross Profit Margin		140.91%
Selling, General & Admin	$13.10M	$48.91M	$2.940M
YoY Change	345.68%	309.42%
% of Gross Profit		10517.2%
Research & Development	$11.57M	$51.32M
YoY Change		125.9%
% of Gross Profit		11036.77%
Depreciation & Amortization	$324.0K	$1.000M
YoY Change		66.67%
% of Gross Profit		215.05%
Operating Expenses	$24.68M	$100.2M	$2.940M
YoY Change	739.35%	189.14%
Operating Profit		-$99.76M
YoY Change		187.78%
Interest Expense	$0.00	$14.23M	$50.00K
YoY Change	-100.0%	2927.45%
% of Operating Profit
Other Income/Expense, Net	$27.51M	$220.4M
YoY Change		-180.93%
Pretax Income	-$2.729M	$120.7M	-$2.900M
YoY Change	-5.9%	-139.3%
Income Tax	$1.000K	$2.000K	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$2.730M	$120.7M	-$2.900M
YoY Change	-5.86%	-139.3%
Net Earnings / Revenue		36561.82%
Basic Earnings Per Share		$1.85
Diluted Earnings Per Share	-$33.67K	$1.70	-$6.59
COMMON SHARES
Basic Shares Outstanding	81.21M shares	65.18M shares
Diluted Shares Outstanding		70.92M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$160.0M	$160.0M	$200.0K
YoY Change	79918.0%	79900.0%	-81.82%
Cash & Equivalents	$160.0M	$160.0M	$23.01M
Short-Term Investments
Other Short-Term Assets	$9.628M	$9.600M	$400.0K
YoY Change	2307.0%	2300.0%	33.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$169.7M	$169.7M	$27.61M
YoY Change	514.44%	28183.33%	1872.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.829M	$12.40M	$2.321M
YoY Change	108.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$173.1M
YoY Change			0.17%
Other Assets	$3.065M	$3.400M	$2.740M
YoY Change	11.86%
Total Long-Term Assets	$16.16M	$16.10M	$8.707M
YoY Change	85.61%	-90.7%	-94.96%
TOTAL ASSETS
Total Short-Term Assets	$169.7M	$169.7M	$27.61M
Total Long-Term Assets	$16.16M	$16.10M	$8.707M
Total Assets	$185.8M	$185.8M	$36.32M
YoY Change	411.63%	6.97%	-79.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.911M	$1.900M	$1.863M
YoY Change	2.58%
Accrued Expenses	$9.785M	$11.00M	$3.064M
YoY Change	219.35%	340.0%	2964.0%
Deferred Revenue	$0.00		$1.914M
YoY Change	-100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$20.91M	$20.90M
YoY Change
Total Short-Term Liabilities	$38.87M	$38.90M	$7.314M
YoY Change	431.41%	1456.0%	3557.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$483.0K	$15.10M	$49.00K
YoY Change	885.71%	118.84%	-99.29%
Total Long-Term Liabilities	$15.07M	$15.10M	$318.5M
YoY Change	-95.27%	118.84%	4515.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.87M	$38.90M	$7.314M
Total Long-Term Liabilities	$15.07M	$15.10M	$318.5M
Total Liabilities	$53.94M	$53.90M	$325.8M
YoY Change	-83.44%	473.4%	4488.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$208.7M		-$329.3M
YoY Change	-36.64%
Common Stock	$1.000K		$1.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$131.9M	$131.9M	-$289.5M
YoY Change
Total Liabilities & Shareholders Equity	$185.8M	$185.8M	$36.32M
YoY Change	411.63%	6.97%	-79.15%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$2.730M	$120.7M	-$2.900M
YoY Change	-5.86%	-139.3%
Depreciation, Depletion And Amortization	$324.0K	$1.000M
YoY Change		66.67%
Cash From Operating Activities	-$14.58M	-$86.71M	-$590.0K
YoY Change	2371.69%	166.53%	63.89%
INVESTING ACTIVITIES
Capital Expenditures	-$239.0K	$2.972M
YoY Change		97.87%
Acquisitions
YoY Change
Other Investing Activities			$20.00K
YoY Change			-100.01%
Cash From Investing Activities	-$238.0K	-$3.090M	$20.00K
YoY Change	-1290.0%	93.0%	-100.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$88.17M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.824M	$226.8M	0.000
YoY Change		407.97%	-100.0%
NET CHANGE
Cash From Operating Activities	-14.58M	-$86.71M	-590.0K
Cash From Investing Activities	-238.0K	-$3.090M	20.00K
Cash From Financing Activities	-3.824M	$226.8M	0.000
Net Change In Cash	-18.64M	$137.0M	-570.0K
YoY Change	3171.05%	1202.66%	-152.29%
FREE CASH FLOW
Cash From Operating Activities	-$14.58M	-$86.71M	-$590.0K
Capital Expenditures	-$239.0K	$2.972M
Free Cash Flow	-$14.34M	-$89.68M
YoY Change		163.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001781162
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	241700000	USD
CY2021	dei	Entity File Number EntityFileNumber	001-39128
CY2021	dei	Entity Registrant Name EntityRegistrantName	Momentus Inc
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1905538
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	3901 N. First Street
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95134
CY2021	dei	City Area Code CityAreaCode	650
CY2021	dei	Local Phone Number LocalPhoneNumber	564-7820
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	81211781	shares
CY2021	dei	Auditor Firm AuditorFirmId	32
CY2021	dei	Auditor Name AuditorName	Armanino LLP
CY2021	dei	Auditor Location AuditorLocation	San Ramon, CA
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160036000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23005000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	197000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	100000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4508000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	169664000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	27613000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2321000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	305000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7604000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	USD
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	2610000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	314000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	415000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3065000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2740000	USD
CY2021Q4	us-gaap	Assets Assets	185825000	USD
CY2020Q4	us-gaap	Assets Assets	36320000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1911000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1863000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3064000	USD
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	20907000	USD
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1914000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1189000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	254000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5075000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	220000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38867000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7314000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1554000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	711000	USD
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5749000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3206000	USD
CY2020Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	314440000	USD
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	0	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7284000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	483000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	49000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15070000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	318478000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	53937000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	325792000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81211781	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81211781	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	142804498	shares
CY2021	us-gaap	Gross Profit GrossProfit	465000	USD
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62510690	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62510690	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	340570000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39866000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-208683000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-329338000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-289472000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185825000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36320000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	-135000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	368000	USD
CY2020	us-gaap	Gross Profit GrossProfit	-3000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51321000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22718000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48905000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11945000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	100226000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	34663000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-99761000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-34666000	USD
CY2021	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	209291000	USD
CY2020	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	-267290000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-37330000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3177000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-17000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-482000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000	USD
CY2021	us-gaap	Interest Expense InterestExpense	14229000	USD
CY2020	us-gaap	Interest Expense InterestExpense	470000	USD
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-7000000	USD
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4960000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-949000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	220417000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-272361000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	120656000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-307026000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-307027000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.90
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65177873	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62643121	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70918777	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62643121	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	14697000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	91000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2771000	USD
CY2020	mnts	Stock Contributed During Period Value Contributed From Co Founders StockContributedDuringPeriodValueContributedFromCoFounders	0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-307027000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-289472000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	336000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18382000	USD
CY2021	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	151000	USD
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	40000000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6999000	USD
CY2021	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136001000	USD
CY2021	mnts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	75114000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	104022000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-307027000	USD
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1092000	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	590000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11729000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	116000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-37330000	USD
CY2020Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	4700000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3177000	USD
CY2021	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	-209291000	USD
CY2020	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	267290000	USD
CY2021	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	9450000	USD
CY2020	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	1500000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-17000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-482000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18452000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2771000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	14373000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3616000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	325000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	760000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1562000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-997000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7042000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1813000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4810000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	211000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1071000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1916000	USD
CY2021	mnts	Increase Decrease In Operating Lease Liability And Operating Right Of Use Asset IncreaseDecreaseInOperatingLeaseLiabilityAndOperatingRightOfUseAsset	-859000	USD
CY2020	mnts	Increase Decrease In Operating Lease Liability And Operating Right Of Use Asset IncreaseDecreaseInOperatingLeaseLiabilityAndOperatingRightOfUseAsset	0	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	11000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-86712000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32534000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2972000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1502000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	118000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	99000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3090000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1601000	USD
CY2021	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30853000	USD
CY2020	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	44650000	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	25000000	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2458000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	336000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	91000	USD
CY2021	mnts	Payments For Repurchase Of Section16 Officer Common Stock PaymentsForRepurchaseOfSection16OfficerCommonStock	151000	USD
CY2020	mnts	Payments For Repurchase Of Section16 Officer Common Stock PaymentsForRepurchaseOfSection16OfficerCommonStock	0	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1500000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2507000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	144000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	37000	USD
CY2021	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	31000	USD
CY2020	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	1000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
CY2021	mnts	Payments Of Stock Issuance Costs Related To Private Placement PaymentsOfStockIssuanceCostsRelatedToPrivatePlacement	4416000	USD
CY2020	mnts	Payments Of Stock Issuance Costs Related To Private Placement PaymentsOfStockIssuanceCostsRelatedToPrivatePlacement	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	128167000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21285000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	226829000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44654000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	137027000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10519000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23520000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13002000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160547000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23520000	USD
CY2021	mnts	Conversion Of Simple Agreement For Future Equity Issuance To Common Stock ConversionOfSimpleAgreementForFutureEquityIssuanceToCommonStock	136001000	USD
CY2020	mnts	Conversion Of Simple Agreement For Future Equity Issuance To Common Stock ConversionOfSimpleAgreementForFutureEquityIssuanceToCommonStock	0	USD
CY2021	mnts	Issuance Of Common Stock Warrant Liabilities Exercised IssuanceOfCommonStockWarrantLiabilitiesExercised	6999000	USD
CY2020	mnts	Issuance Of Common Stock Warrant Liabilities Exercised IssuanceOfCommonStockWarrantLiabilitiesExercised	0	USD
CY2021	mnts	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	2610000	USD
CY2020	mnts	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	USD
CY2021	mnts	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses	0	USD
CY2020	mnts	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses	506000	USD
CY2021	mnts	Warrant Liabilities Recognized Upon The Closing Of The Reverse Recapitalization WarrantLiabilitiesRecognizedUponTheClosingOfTheReverseRecapitalization	31225000	USD
CY2020	mnts	Warrant Liabilities Recognized Upon The Closing Of The Reverse Recapitalization WarrantLiabilitiesRecognizedUponTheClosingOfTheReverseRecapitalization	0	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8501000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2500000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	353000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	Nature of Operations<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Momentus Inc. (together with its consolidated subsidiaries “Momentus” or the “Company”) is a U.S. commercial space company that plans to offer in-space infrastructure services, including in-space transportation, hosted payloads and in-orbit services. Momentus believes it can make new ways of operating in space possible with its planned in-space transfer and service vehicles that will be powered by an innovative water plasma-based propulsion system that is under development. The Company anticipates flying its Vigoride vehicle to Low Earth Orbit on a third-party launch provider as early as June 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to receipt of licenses and government approvals, and successful completion of our current efforts to get the system ready for flight.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background and Business Combination</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021 (the “Closing Date”), the Company consummated a merger pursuant to a certain agreement and plan of merger, dated October 7, 2020, and as amended on March 5, 2021, April 6, 2021, and June 29, 2021 (the “Merger Agreement”), by and among Stable Road Acquisition Corp (“SRAC”), Project Marvel First Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of SRAC (“First Merger Sub”), and Project Marvel Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of SRAC (“Second Merger Sub”), pursuant to which First Merger Sub merged with and into Momentus Inc., a Delaware corporation (“Legacy Momentus”) with Legacy Momentus as the surviving corporation of the First Merger Sub, and immediately following which Legacy Momentus merged with and into the Second Merger Sub, with the Second Merger Sub as the surviving entity (the “Business Combination”). In connection with the closing of the Business Combination (the “Closing”), the Company changed its name from Stable Road Acquisition Corp. to Momentus Inc., and Legacy Momentus changed its name to Momentus Space, LLC. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was accounted for as a reverse recapitalization under ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 805") in accordance with accounting principles generally accepted in the United States (“GAAP”). Under this method of accounting, SRAC, who was the legal acquirer, is treated as the “acquired” company for financial reporting purposes and Legacy Momentus is treated as the accounting acquirer. Accordingly, for accounting purposes, the Business Combination is treated as the equivalent of a capital transaction in which Legacy Momentus issued stock for the net assets of SRAC, with no goodwill or other intangible assets recorded, and Legacy Momentus’ financial statements became those of the Company. Reported shares and earnings per share available to holders of the Company’s common stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. See Note 3 for more information.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended and Restated Certificate of Incorporation of the Company, at the Closing, each share of SRAC’s Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock”), converted into one share of SRAC’s Class A Common Stock. After the Closing and following the effectiveness of the Second Amended and Restated Certificate of Incorporation of the Company, each share of Class A Common Stock was automatically reclassified, redesignated and changed into one validly issued, fully paid and non-assessable share of the Company’s Common Stock, par value $0.00001 per share (the “Common Stock”), without any further action by the Company or any stockholder thereof. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, SRAC’s units, public shares, and public warrants were listed on the Nasdaq under the symbols “SRACU,” “SRAC,” and “SRACW,” respectively. On August 13, 2021, the Company's Class A common stock and public warrants began trading on the Nasdaq, under the symbols “MNTS” and “MNTSW,” respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2020 and July 15, 2021, SRAC entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 11,000,000 shares of the Company’s Class A common stock at $10.00 per share for aggregate gross proceeds of $110.0 million (the “PIPE Investment”). The PIPE Investors were also granted an equal number of private warrants to purchase the Company’s Class A common stock at $11.50 per share. The warrants were recorded as a derivative liability under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the warrant liability was initially valued at $30.5 million. See Note 11 for more information. The PIPE Investment was consummated concurrently with the closing of the Business Combination.</span>
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	3000000	USD
CY2021Q2	mnts	Number Of Launch Agreements Terminated NumberOfLaunchAgreementsTerminated	2	agreement
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, we modified the presentation of cash flows related to the Business Combination. The presented impact of the issuance costs allocated to expense (described in Note 3), was moved into the issuance costs line. Additionally the presentation of capitalized issuance costs which were paid during the two quarters prior to the Business Combination was updated to present those expenditures within cash flows from financing activities, rather than cash flows from operations. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year’s financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, stockholders’ deficit, income, expenses or net losses previously reported.</span></div>
CY2021	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Management bases its estimates on historical experience and on various other factors it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Accordingly, actual results could differ from those estimates. Significant estimates inherent in the preparation of the consolidated financial statements include, but are not limited to, accounting for useful lives of property, machinery and equipment, net, intangible assets, net, accrued liabilities, income taxes including deferred tax assets and liabilities, impairment valuation, stock-based awards, SAFE notes and warrant liabilities.
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	-100000	USD
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1400000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1600000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2600000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1600000	USD
CY2021	mnts	Contract With Customer Liability Revenue Recognized For Cancelled Contracts ContractWithCustomerLiabilityRevenueRecognizedForCancelledContracts	300000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	550000	USD
CY2021Q3	mnts	Reverse Recapitalization Percentage Of Voting Interests Sold ReverseRecapitalizationPercentageOfVotingInterestsSold	1
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	238400000	USD
CY2021Q3	mnts	Reverse Recapitalization Redemptions ReverseRecapitalizationRedemptions	35600000	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22927491	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21787929	shares
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	560000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents in banks that management believes are creditworthy, however deposits may exceed federally insured limits.
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	128400000	USD
CY2021Q3	mnts	Reverse Recapitalization Public Investment ReverseRecapitalizationPublicInvestment	172500000	USD
CY2021Q3	mnts	Reverse Recapitalization Impact On Shareholders Equity ReverseRecapitalizationImpactOnShareholdersEquity	8500000	USD
CY2021Q3	mnts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	27800000	USD
CY2021Q3	mnts	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	4800000	USD
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriod	P6M
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Stock Price Trigger ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodStockPriceTrigger	12
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdTradingDays	20	tradingDay
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdConsecutiveTradingDays	30	tradingDay
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	USD
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	USD
CY2020	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	200000	USD
CY2021Q4	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	4870000	USD
CY2020Q4	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	1452000	USD
CY2021Q4	mnts	Prepaid Launch Costs Current PrepaidLaunchCostsCurrent	0	USD
CY2020Q4	mnts	Prepaid Launch Costs Current PrepaidLaunchCostsCurrent	2260000	USD
CY2021Q4	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	4562000	USD
CY2020Q4	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	796000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4508000	USD
CY2021Q4	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	3000000	USD
CY2020Q4	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	2400000	USD
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	USD
CY2021	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	USD
CY2020	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	1500000	USD
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6656000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3103000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1827000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	782000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2321000	USD
CY2021	us-gaap	Depreciation Depreciation	1000000	USD
CY2020	us-gaap	Depreciation Depreciation	600000	USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000.00	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30000.00	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	57000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	57000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	43000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	43000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	99000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	20000.00	USD
CY2021Q4	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	2	lease
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1700000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1742000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	272000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	590000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	24000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9000	USD
CY2021	us-gaap	Lease Cost LeaseCost	2351000	USD
CY2020	us-gaap	Lease Cost LeaseCost	305000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7604000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1189000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	254000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7284000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8473000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	326000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1634000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1533000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1580000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1627000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1674000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2026000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10074000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1601000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8473000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4121000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	268000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3862000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1371000	USD
CY2021Q4	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	1240000	USD
CY2020Q4	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	517000	USD
CY2021Q4	mnts	Accrued Offering Costs Current AccruedOfferingCostsCurrent	0	USD
CY2020Q4	mnts	Accrued Offering Costs Current AccruedOfferingCostsCurrent	506000	USD
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	163000	USD
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	328000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	399000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	74000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3064000	USD
CY2021	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30900000	USD
CY2021Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	78000000	USD
CY2021Q3	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136000000	USD
CY2021Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Maximum Amount SharesSubjectToMandatoryRedemptionSettlementTermsMaximumAmount	0	USD
CY2020Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Maximum Amount SharesSubjectToMandatoryRedemptionSettlementTermsMaximumAmount	314400000	USD
CY2021	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	209300000	USD
CY2020	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	-267300000	USD
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	20907000	USD
CY2021Q3	mnts	Common And Preferred Stock Shares Authorized CommonAndPreferredStockSharesAuthorized	270000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22927491	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2021Q3	mnts	Common Stock Percentage Of Ownership After Reverse Recapitalization CommonStockPercentageOfOwnershipAfterReverseRecapitalization	1
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7422995	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.20
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y5M26D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	130564000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1535804	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17487000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1830842	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4056349	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.27
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15825000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2649701	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21787929	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.26
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y2M12D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10379000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4056349	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.27
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y4M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	15825000	USD
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10400000	USD
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	55600000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18452000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2771000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18452000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2771000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	120654000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-307027000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65177873	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62643121	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5438952	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	301952	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70918777	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62643121	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.70
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.90
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	10216000	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	11300000	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fourth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Fifth Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Due After Five Years UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears	0	USD
CY2021Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	21516000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	120656000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-307026000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	120656000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17900000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-307026000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	25338000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-64475000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-8446000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.070
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3152000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3426000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.028
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	56588000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.184
CY2021	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	51790000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.429
CY2020	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	171000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.001
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1333000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.011
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1070000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.003
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	336000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.003
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	268000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.001
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	32300000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.268
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11843000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.039
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	16473000	USD
CY2020Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	567000	USD
CY2021Q4	mnts	Deferred Tax Assets Start Up And Organizational Costs DeferredTaxAssetsStartUpAndOrganizationalCosts	15311000	USD
CY2020Q4	mnts	Deferred Tax Assets Start Up And Organizational Costs DeferredTaxAssetsStartUpAndOrganizationalCosts	4280000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10350000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8812000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3758000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2340000	USD
CY2021Q4	mnts	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	2381000	USD
CY2020Q4	mnts	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	91000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1457000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	171000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	893000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	889000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1070000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	504000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	586000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	289000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	26000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	14000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	52305000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17957000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50168000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17869000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2137000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	88000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2137000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	88000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2137000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	88000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	50200000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	780000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	62000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	535000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1253000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	54500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	15300000	USD
CY2021	mnts	Number Of Leases Resulting In Deferred Tax Assets And Liabilities NumberOfLeasesResultingInDeferredTaxAssetsAndLiabilities	3	lease
CY2021Q4	mnts	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	2400000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2100000	USD

Files In Submission

Name	View Source	Status
0001781162-22-000023-index-headers.html	Edgar Link	pending
0001781162-22-000023-index.html	Edgar Link	pending
0001781162-22-000023.txt	Edgar Link	pending
0001781162-22-000023-xbrl.zip	Edgar Link	pending
a20211231-ex311xceo.htm	Edgar Link	pending
a20211231-ex312xcfo.htm	Edgar Link	pending
a20211231-ex321xceo.htm	Edgar Link	pending
a20211231-ex322xcfo.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mnts-20211231.htm	Edgar Link	pending
mnts-20211231.xsd	Edgar Link	pending
mnts-20211231_cal.xml	Edgar Link	unprocessable
mnts-20211231_def.xml	Edgar Link	unprocessable
mnts-20211231_htm.xml	Edgar Link	completed
mnts-20211231_lab.xml	Edgar Link	unprocessable
mnts-20211231_pre.xml	Edgar Link	unprocessable
momentusconsent-final.htm	Edgar Link	pending
momentusconsent-final001.jpg	Edgar Link	pending
momenus-exsxdescriptiono.htm	Edgar Link	pending
momenus-exsxdescriptiono001.jpg	Edgar Link	pending
momenus-exsxdescriptiono002.jpg	Edgar Link	pending
momenus-exsxdescriptiono003.jpg	Edgar Link	pending
momenus-exsxdescriptiono004.jpg	Edgar Link	pending
momenus-exsxdescriptiono005.jpg	Edgar Link	pending
momenus-exsxdescriptiono006.jpg	Edgar Link	pending
momenus-exsxdescriptiono007.jpg	Edgar Link	pending
momenus-exsxdescriptiono008.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNTS
Momentus Inc. Stock $mnts

2021 Q4 Form 10-K Financial Statement

#000178116222000023 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS Momentus Inc. Stock $mnts

2021 Q4 Form 10-K Financial Statement

#000178116222000023 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS
Momentus Inc. Stock $mnts